PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 272 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $38,601,378 | -22.2% | 4,622,920 | +23.9% | 0.00% | -25.0% |
Q2 2023 | $49,619,302 | -51.0% | 3,730,775 | -57.3% | 0.00% | -20.0% |
Q1 2023 | $101,166,748 | +8107.7% | 8,736,334 | +5697.8% | 0.01% | – |
Q4 2022 | $1,232,590 | +12.8% | 150,683 | -20.0% | 0.00% | – |
Q3 2022 | $1,093,000 | -79.7% | 188,300 | -84.6% | 0.00% | -100.0% |
Q2 2022 | $5,395,000 | -59.9% | 1,220,723 | -17.5% | 0.00% | 0.0% |
Q1 2022 | $13,463,000 | -63.3% | 1,479,433 | -17.5% | 0.00% | -66.7% |
Q4 2021 | $36,670,000 | +444.8% | 1,792,291 | +580.4% | 0.00% | +200.0% |
Q3 2021 | $6,731,000 | -26.9% | 263,411 | +0.0% | 0.00% | 0.0% |
Q2 2021 | $9,209,000 | -90.7% | 263,338 | -91.2% | 0.00% | -87.5% |
Q1 2021 | $99,136,000 | +1982620.0% | 2,976,162 | +1653323.3% | 0.01% | – |
Q4 2020 | $5,000 | +400.0% | 180 | +252.9% | 0.00% | – |
Q3 2020 | $1,000 | -99.8% | 51 | -99.9% | 0.00% | – |
Q4 2014 | $470,000 | – | 60,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |